CRGX vs. PRME, RLAY, PROK, MESO, RGNX, HLVX, HUMA, IMTX, KYTX, and CGEM
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Prime Medicine (PRME), Relay Therapeutics (RLAY), ProKidney (PROK), Mesoblast (MESO), REGENXBIO (RGNX), HilleVax (HLVX), Humacyte (HUMA), Immatics (IMTX), Kyverna Therapeutics (KYTX), and Cullinan Oncology (CGEM). These companies are all part of the "biological products, except diagnostic" industry.
CARGO Therapeutics (NASDAQ:CRGX) and Prime Medicine (NYSE:PRME) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment.
In the previous week, Prime Medicine had 5 more articles in the media than CARGO Therapeutics. MarketBeat recorded 11 mentions for Prime Medicine and 6 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.44 beat Prime Medicine's score of 0.61 indicating that CARGO Therapeutics is being referred to more favorably in the media.
CARGO Therapeutics' return on equity of 0.00% beat Prime Medicine's return on equity.
CARGO Therapeutics currently has a consensus target price of $29.00, indicating a potential upside of 62.28%. Prime Medicine has a consensus target price of $15.09, indicating a potential upside of 132.17%. Given Prime Medicine's higher possible upside, analysts clearly believe Prime Medicine is more favorable than CARGO Therapeutics.
93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 70.4% of Prime Medicine shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by company insiders. Comparatively, 24.3% of Prime Medicine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Prime Medicine received 7 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 72.22% of users gave Prime Medicine an outperform vote.
Summary
CARGO Therapeutics beats Prime Medicine on 7 of the 12 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
